2024-12-25 21:32:12
Bridge Biotherapeutics Presents Phase 2a Clinical Trial Results For BBT-401, a Drug Candidate to Treat Ulcerative Colitis
Corporate/ 2023-07-24
Bridge Biotherapeutics Presents Phase 2a...

BBT-401 meets safety endpoints achieved in previous clinical studies The drug candidate did not achieve an improved clinical response compar...

Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Initiation of Phase II Study of naronapride in patients with gastroparesis
Health/ 2023-07-22
Renexxion Ireland Ltd. and Dr. Falk Phar...

Randomized,double-blind,placebo-controlled study to evaluate efficacy of novel pan-GI prokinetic in patients with gastroparesis

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release